Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Centessa Pharmaceuticals Plc (CNTA)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 131,000,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Centessa Pharmaceuticals is a pharmaceutical company that develops and delivers life-altering and life-enhancing medicines to patients. Co.'s product pipeline includes: Lixivaptan, a vasopressin V2 receptor small molecule inhibitor; SerpinPC, an activated protein C inhibitor for the treatment of hemophilia A and B; Imgatuzumab, an anti-EGFR monoclonal antibody for the treatment of cutaneous squamous cell carcinoma and for the treatment of other solid tumors in the context of combination treatment with immunotherapy; and ZF874, a small molecule chemical chaperone folding corrector of the Z variant of alpha-1-antitrypsin for the treatment of alpha-1-antitrypsin deficiency.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 462,585 462,585
Total Buy Value $0 $0 $5,865,243 $5,865,243
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 2 2
Total Shares Sold 106,000 271,964 752,477 1,723,840
Total Sell Value $2,914,124 $6,523,832 $13,610,145 $29,270,856
Total People Sold 3 3 7 7
Total Sell Transactions 5 16 40 75
End Date 2025-11-09 2025-08-08 2025-02-07 2024-02-08

   
Records found: 293
  Page 1 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Accardi Mario Alberto President, Orexin Program   •       –      –    2025-12-09 4 AS $28.70 $288,289 D/D (10,000) 178,801     -
   Accardi Mario Alberto President, Orexin Program   •       –      –    2025-12-08 4 AS $30.00 $300,000 D/D (10,000) 188,801     -
   Accardi Mario Alberto President, Orexin Program   •       –      –    2025-12-08 4 OE $9.53 $47,650 D/D 5,000 198,801     -
   Hussain Iqbal J General Counsel   •       –      –    2025-11-17 4 AS $27.64 $165,835 D/D (6,000) 105,386     -
   Hussain Iqbal J General Counsel   •       –      –    2025-11-17 4 OE $5.84 $35,040 D/D 6,000 111,386     -
   Bush Tia L Chief Technology & Quality Ofc   •       –      –    2025-11-17 4 AS $28.00 $1,120,000 D/D (40,000) 121,503     -
   Bush Tia L Chief Technology & Quality Ofc   •       –      –    2025-11-17 4 OE $9.42 $376,800 D/D 40,000 161,503     -
   Bush Tia L Chief Technology & Quality Ofc   •       –      –    2025-11-12 4 AS $26.00 $1,040,000 D/D (40,000) 121,503     -
   Bush Tia L Chief Technology & Quality Ofc   •       –      –    2025-11-12 4 OE $9.42 $376,800 D/D 40,000 161,503     -
   Accardi Mario Alberto President, Orexin Program   •       –      –    2025-11-01 4 D $24.90 $14,766 D/D (593) 193,801     -
   Accardi Mario Alberto President, Orexin Program   •       –      –    2025-10-27 4 AS $25.00 $200,000 D/D (8,000) 194,394     -
   Accardi Mario Alberto President, Orexin Program   •       –      –    2025-10-27 4 OE $8.01 $40,050 D/D 5,000 202,394     -
   Hussain Iqbal J General Counsel   •       –      –    2025-10-15 4 AS $22.41 $134,439 D/D (6,000) 105,386     -
   Hussain Iqbal J General Counsel   •       –      –    2025-10-15 4 OE $5.84 $35,040 D/D 6,000 111,386     -
   Bush Tia L Chief Technology & Quality Ofc   •       –      –    2025-09-24 4 AS $24.00 $840,000 D/D (35,000) 121,503     -
   Bush Tia L Chief Technology & Quality Ofc   •       –      –    2025-09-24 4 OE $9.42 $329,700 D/D 35,000 156,503     -
   Accardi Mario Alberto President, Orexin Program   •       –      –    2025-09-16 4 AS $21.33 $174,846 D/D (8,172) 197,394     -
   Hussain Iqbal J General Counsel   •       –      –    2025-09-15 4 AS $21.85 $131,101 D/D (6,000) 105,386     -
   Hussain Iqbal J General Counsel   •       –      –    2025-09-15 4 OE $5.84 $35,040 D/D 6,000 111,386     -
   Hussain Iqbal J General Counsel   •       –      –    2025-09-10 4 AS $22.00 $440,000 D/D (20,000) 105,386     -
   Hussain Iqbal J General Counsel   •       –      –    2025-09-10 4 OE $5.84 $116,800 D/D 20,000 125,386     -
   Bush Tia L Chief Technology & Quality Ofc   •       –      –    2025-09-10 4 AS $22.00 $550,000 D/D (25,000) 121,503     -
   Bush Tia L Chief Technology & Quality Ofc   •       –      –    2025-09-10 4 OE $9.42 $235,500 D/D 25,000 146,503     -
   Hussain Iqbal J General Counsel   •       –      –    2025-09-09 4 AS $20.01 $400,102 D/D (20,000) 105,386     -
   Hussain Iqbal J General Counsel   •       –      –    2025-09-09 4 OE $5.84 $116,800 D/D 20,000 125,386     -
  293 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2026 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us